Prostate Cancer Review

Ekaterina Kachur, PharmD

Disclosures

US Pharmacist. 2018;43(8):HS7-13. 

In This Article

Conclusion

While some controversy remains regarding prostate cancer screening, most organizations incorporate shared decision-making and patient life expectancy as a core consideration. Pharmacists may play an important role in consulting and educating patients about the screening tests, treatments, and related benefits and harms. Enhanced risk-classification methods and expanded treatment options allow pharmacists to counsel patients regarding therapy based on cancer prognosis and patient preference. ADT remains the standard of care for newly diagnosed metastatic disease and an important option in the management of higher risk localized cancer. Pharmacists are well-equipped to provide patient counseling and management of complications of ADT.

Comments

3090D553-9492-4563-8681-AD288FA52ACE

processing....